Tiny trial aims to perfect brain stimulation timing for Parkinson's

NCT ID NCT07139093

Completed Knowledge-focused Sponsor: Universitätsklinikum Hamburg-Eppendorf Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 01, 2026 · Updated 3 times

Summary

This study tests a device that synchronizes two types of brain stimulation — deep brain stimulation (DBS) and transcranial alternating current stimulation (tACS) — in people with Parkinson's disease. Only 2 participants will be enrolled to see if the device can lock the timing of the two stimulations accurately. The goal is purely technical: to confirm the interface works, not to treat symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: device: synchronized tACS and DBS
What this could lead to: If successful, this could enable future studies that explore whether precisely timed brain stimulation improves symptoms in Parkinson's disease.
What could go wrong: This is a very early, tiny trial with only 2 participants, focused on testing the equipment, not on treating the disease. It may not lead to any direct benefit for patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEEP BRAIN STIMULATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dystonic disorder essential tremor Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEEP BRAIN STIMULATION PARKINSON'S DISEASE (PD)

Contacts and locations

Locations

University Medical Center Hamburg-Eppendorf

Hamburg, 20246, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.